Similar articles

• [Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].

  Gabay C. Gabay C. Rev Med Suisse Romande. 2000 Jun;120(6):529-33. Rev Med Suisse Romande. 2000. PMID: 11014098 Review. French. No abstract available.
• Acute inflammatory arthritis: interleukin-1 blockade: a magic wand for gout?

  Bardin T. Bardin T. Nat Rev Rheumatol. 2009 Nov;5(11):594-6. doi: 10.1038/nrrheum.2009.213. Nat Rev Rheumatol. 2009. PMID: 19865087 No abstract available.
• IL-1 as a target in inflammation.

  Ito Y, Kaneko N, Iwasaki T, Morikawa S, Kaneko K, Masumoto J. Ito Y, et al. Endocr Metab Immune Disord Drug Targets. 2015;15(3):206-11. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 26333726 Review.
• Human interleukin-1 receptor antagonist is expressed in liver.

  Steinkasserer A, Estaller C, Weiss EH, Sim RB. Steinkasserer A, et al. FEBS Lett. 1992 Sep 21;310(1):60-2. doi: 10.1016/0014-5793(92)81146-d. FEBS Lett. 1992. PMID: 1382023
• Native interleukin 1 inhibitors.

  Larrick JW. Larrick JW. Immunol Today. 1989 Feb;10(2):61-6. doi: 10.1016/0167-5699(89)90308-3. Immunol Today. 1989. PMID: 2526643 Review.